iXCells Biotechnologies Launches iPSCore™ Platform for Generating Highly Characterized iPSC-derived Human Cell Models

iXCells Biotechnologies focuses on creating a broad portfolio of iPSC-derived off-the-shelf and custom cell models from healthy and patient donors to make "clinical-trials-in-a-plate" a reality SAN DIEGO -- iXCells Biotechnologies USA, Inc. ("iXCells"), a leading cell technology company specializing in the generation of predictive human disease models is pleased to announce the launch of its [...]

MaxCyte and Ori Biotech Announce Collaboration

MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® platforms to improve the yield of gene-edited T cells and shorten manufacturing timelines ROCKVILLE, MD AND LONDON, UK -  MaxCyte, Inc. (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform [...]

Cytiva completing 1.6 billion USD in strategic investments to further enhance global supply chain and customer benefits

Faster delivery and productivity gains available thanks to expanded manufacturing capacity in chromatography resins, filtration, single-use bags and cell culture Most major projects completed in Europe and Asia-Pacific, US resins site slated to be up and running in 2028 Cytiva, a Danaher company and global life sciences leader, has completed significant expansion projects in several [...]

PEPperPRINT GmbH Launches cLIFT Technology for Next-Generation Peptide Microarrays

HEIDELBERG, Germany – PEPperPRINT, a global leader in peptide microarray technology, celebrates its 15th anniversary with the launch of its next-generation peptide microarray platform: cLIFT, short for combinatorial Laser-Induced Forward Transfer. The new technology dramatically expands peptide printing capabilities and paves the way for innovative biomedical research applications. Developed in collaboration with Dr. Felix Loeffler of the Max Planck Institute of Colloids [...]

ScaleReady Announces a G-Rex® Grant has been awarded to Immuneel Therapeutics

ST. PAUL, Minn. -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support process development aimed at enhancing the scalability and cost-effectiveness of CAR-T cell manufacturing in India. "The blood cancer burden on India's population is substantial, around 120,000 new [...]

Sale of Oxford Instruments’ quantum business, NanoScience

Oxford Instruments plc, a leading provider of high technology products and services to industry and scientific research communities, today announces that it has entered into a binding agreement to sell its quantum-focused business Oxford Instruments NanoScience (“NanoScience”) to Quantum Design, International Inc. for a £60m total cash consideration (“Sale”), including up to £3m of deferred [...]

CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development

Extends capabilities of industry-leading PhysioMimix DILI assay for comparative studies between animal species and human Generates deeper insights into inter-species differences to de-risk development pipelines and minimize animal testing  Cambridge, UK -- CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system [...]

Refeyn Announces Leadership Transition: Jonathan Flint Steps Down as Chairman, Jean-Paul Mangeolle Appointed as Successor

Oxford, UK – Refeyn, a leader in mass photometry and analytical instrumentation, today announced that Jonathan Flint is stepping down as Chairman of the Board of Directors after completing two successful three-year terms. Flint’s tenure has been marked by significant growth and innovation, and the company extends its deepest gratitude for his exceptional leadership and dedication. Under [...]

ZwickRoell Unveils the pharMed360 Advantage – An Innovative Approach to Pharmaceutical and Medical Device Testing Equipment & Services

KENNESAW, Ga. -- ZwickRoell is excited to announce a groundbreaking strategy in the rapidly expanding field of pharmaceutical and medical device testing equipment & services with the introduction of its pharMed360 initiative. This new approach provides the growing medical and pharmaceutical industries with a comprehensive group of dedicated industry focused professionals. This team is prepared to [...]

Alamar Biosciences, Alzheimer’s Disease Data Initiative, and Gates Ventures Unite in Global Partnership to Advance Translational Research in Alzheimer’s Disease

Multi-center project will profile over 40,000 samples using ultra-sensitive NULISA™ technology. Fremont, CA – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, the Alzheimer’s Disease Data Initiative and Gates Ventures today announced a strategic partnership with the goal to generate one of the largest proteomic datasets linked to clinical outcomes in [...]

Access IBO on Knowledge Center